BeStock  
Stocks › Biotechnology › PHVS

Pharvaris PHVS

US equityMarket cap rank #2618Biotechnology
$31.28 −$0.38 (-1.20%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $31.28 0.00%
Open$31.41
Prev close$31.66
Day range$30.43 – $31.99
Volume464.0K
Market cap$2.21B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership99.9%+2.32 pts vs. prior quarter
Institutions holding145+1 vs. prior quarter
Insider trades (recent)1 buys / 49 sellsNet selling
Short interest3.62% of floatDays to cover 3.6 · as of 30 Oct 2026
Short-sale volume share14.4%5-day average of daily volume

Short-sale volume as % of daily volume

6%13%20%27%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$574.3K (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

+$1.0MSuper−$447.9KBig+$3.6MMid+$2.3MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 38.8% of shares outstanding.

Largest holders

  • FMR9.86%
  • General Atlantic Service Company, L.P.9.33%
  • Foresite Capital Management, LLC7.75%
  • venBio LLC6.61%
  • Viking Global Investors LP5.20%
  • EQT Life Sciences5.07%
  • Eqt Fund Management S.à R.L.4.88%
  • Deerfield Management Company, L.P.4.81%

By investor type

  • VC/PE Fund45.00%
  • Hedge Fund29.90%
  • Mutual Fund22.92%
  • Individual/Insider2.11%
  • Public Company1.16%
  • Private Company0.83%
  • Government Pension Fund0.06%
  • Family Office/Trust0.05%

Reported short interest has risen from 2.56% to 3.62% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
FMR Mutual Fund 2026/Q3 +356,548 9.9%
Morgan Stanley Public Company 2026/Q3 +315,493 0.6%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +315,493 0.6%
Jane Street Group, LLC Private Company 2026/Q3 +197,030 0.5%
BlackRock Mutual Fund 2026/Q3 +195,267 1.4%
Polar Capital Holdings Plc Mutual Fund 2026/Q3 +1,545,373 3.3%
TCG Crossover Management, LLC VC/PE Fund 2026/Q3 +1,008,229 1.4%
Point72 Asset Management, L.P. Hedge Fund 2026/Q3 +634,184 2.3%
Jones Hill Capital LP Hedge Fund 2026/Q3 +510,865 1.0%
DV Equities, LLC Mutual Fund 2026/Q3 +482,524 0.7%
Foresite Capital Management, LLC VC/PE Fund 2026/Q3 +470,017 7.8%
Seven Fleet Capital Management LP Hedge Fund 2026/Q3 +457,804 1.1%
Octagon Capital Advisors LP Hedge Fund 2026/Q3 +291,721 0.7%
Alyeska Investment Group, L.P. Hedge Fund 2026/Q3 +281,829 0.6%
FMR Mutual Fund 2026/Q3 +280,800 9.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
11 Nov 2026 Peng Lu President Sale to Issuer -226 $34.18 70,808
11 Oct 2026 Peng Lu President Sale to Issuer -226 $31.10 70,443
22 Sep 2026 Viviane Monges Independent Non-Executive Director Derivative Exercise and Sale -11,969 $33.05 5,500
21 Sep 2026 Hans J. G. C. Schikan Independent & Non-Executive Vice Chairman Derivative Exercise and Sale -800 $36.19 115,167
21 Sep 2026 Peng Lu President Derivative Exercise and Retained +45,308 $2.59 70,078
20 Sep 2026 David Nassif CFO, Chief Legal Officer & Corporate Secretary Other Disposition -500 – 113,800
20 Sep 2026 David Nassif CFO, Chief Legal Officer & Corporate Secretary Open Market Disposition -6,000 $36.47 113,800
16 Sep 2026 Robert Glassman Independent Non-Executive Director Derivative Exercise and Sale -14,493 $38.56 10,500
16 Sep 2026 Berndt Axel Modig Chief Executive Officer Other Disposition -300,000 $35.00 778,334
16 Sep 2026 Hans J. G. C. Schikan Independent & Non-Executive Vice Chairman Private Disposition -200,000 $35.00 115,167
16 Sep 2026 Elisabeth Bjork Non-Executive Director Derivative Exercise and Sale -52,500 $37.89 9,667
16 Sep 2026 Anne Lesage Chief Early Development Officer Open Market Disposition -20,000 $38.27 97,653
16 Sep 2026 Peng Lu President Derivative Exercise and Sale -100,000 $35.00 24,770
14 Sep 2026 Robert Glassman Independent Non-Executive Director Derivative Exercise and Sale -8,667 $38.27 10,500
14 Sep 2026 Wim Souverijns Chief Commercial Officer Automatic Disposition -6,090 $38.99 39,021
14 Sep 2026 Stefan Abele Chief Technology Operations Officer Open Market Disposition -1,400 $39.24 39,068
14 Sep 2026 Stefan Abele Chief Technology Operations Officer Derivative Exercise and Sale -45,000 $38.14 39,068
13 Sep 2026 Berndt Axel Modig Chief Executive Officer Automatic Disposition -2,291 $39.40 1,078,334
13 Sep 2026 Wim Souverijns Chief Commercial Officer Derivative Exercise and Sale -20,000 $39.31 39,021
13 Sep 2026 Peng Lu President Sale to Issuer -226 $38.02 24,770

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 2,539,475 3.6% 3.6
15 Oct 2026 2,465,342 3.5% 4.0
30 Sep 2026 2,007,998 2.9% 2.8
15 Sep 2026 1,784,789 2.5% 1.2
31 Aug 2026 2,160,966 3.1% 3.4
14 Aug 2026 1,775,021 2.6% 2.8

Discussion

No comments yet — be the first to weigh in on PHVS.

Sign in to join the discussion.

Scroll to Top